CN101742908A - 治疗用吡唑并喹啉衍生物 - Google Patents

治疗用吡唑并喹啉衍生物 Download PDF

Info

Publication number
CN101742908A
CN101742908A CN200880024823A CN200880024823A CN101742908A CN 101742908 A CN101742908 A CN 101742908A CN 200880024823 A CN200880024823 A CN 200880024823A CN 200880024823 A CN200880024823 A CN 200880024823A CN 101742908 A CN101742908 A CN 101742908A
Authority
CN
China
Prior art keywords
compound
general formula
alkyl
pharmaceutically acceptable
tautomers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880024823A
Other languages
English (en)
Chinese (zh)
Inventor
艾伦·P·卡普兰
瓦沙·古普塔
扬·W·F·瓦斯利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helicon Therapeutics Inc
Original Assignee
Helicon Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helicon Therapeutics Inc filed Critical Helicon Therapeutics Inc
Publication of CN101742908A publication Critical patent/CN101742908A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN200880024823A 2007-06-08 2008-06-06 治疗用吡唑并喹啉衍生物 Pending CN101742908A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94300507P 2007-06-08 2007-06-08
US60/943,005 2007-06-08
PCT/US2008/066201 WO2008154438A1 (en) 2007-06-08 2008-06-06 Therapeutic pyrazoloquinoline derivatives

Publications (1)

Publication Number Publication Date
CN101742908A true CN101742908A (zh) 2010-06-16

Family

ID=40096440

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880024823A Pending CN101742908A (zh) 2007-06-08 2008-06-06 治疗用吡唑并喹啉衍生物

Country Status (13)

Country Link
US (2) US7872002B2 (enExample)
EP (1) EP2166852B1 (enExample)
JP (1) JP2010529143A (enExample)
KR (1) KR20100039331A (enExample)
CN (1) CN101742908A (enExample)
AT (1) ATE544344T1 (enExample)
AU (1) AU2008261884A1 (enExample)
BR (1) BRPI0812366A2 (enExample)
CA (1) CA2688395A1 (enExample)
ES (1) ES2386168T3 (enExample)
IL (1) IL202270A0 (enExample)
MX (1) MX2009013202A (enExample)
WO (1) WO2008154438A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105294648A (zh) * 2015-11-30 2016-02-03 山东罗欣药业集团股份有限公司 一种西他沙星的制备方法
CN108431000A (zh) * 2015-11-16 2018-08-21 基础应用医学研究基金会 作为dna甲基转移酶抑制剂的新型化合物
WO2022037631A1 (zh) * 2020-08-21 2022-02-24 浙江海正药业股份有限公司 杂环类衍生物及其制备方法和用途

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2483728T3 (es) * 2007-06-08 2014-08-07 Dart Neuroscience (Cayman) Ltd Derivados terapéuticos de pirazolonafatiridina
ES2386168T3 (es) * 2007-06-08 2012-08-10 Helicon Therapeutics, Inc. Derivados de pirazoloquinolina terapéuticos
US7863266B2 (en) * 2007-06-08 2011-01-04 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline urea derivatives
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3204126A1 (de) * 1982-02-06 1983-08-11 Bayer Ag, 5090 Leverkusen Pyrazoloxazine, -thiazine, -chinoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4814450A (en) 1984-07-09 1989-03-21 Ciba-Geigy Corporation Certain ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives
JPS61112075A (ja) * 1984-11-05 1986-05-30 Shionogi & Co Ltd チエニルピラゾロキノリン誘導体
EP0214092A1 (en) 1985-08-08 1987-03-11 Ciba-Geigy Ag Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone
US5334595A (en) * 1992-10-23 1994-08-02 Sterling Winthrop Inc. Pyrazoloquinolones as anticancer agents
GB9716347D0 (en) * 1997-08-01 1997-10-08 Merck Sharp & Dohme Therapeutic compounds
TWI271406B (en) 1999-12-13 2007-01-21 Eisai Co Ltd Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
GB0108475D0 (en) * 2001-04-04 2001-05-23 Merck Sharp & Dohme New compounds
JP3896309B2 (ja) * 2001-07-09 2007-03-22 ファイザー株式会社 プロテインキナーゼｃ阻害物質としてのピラゾロキノリノン誘導体
ATE425164T1 (de) 2002-12-16 2009-03-15 Active Biotech Ab Tetrazyklische immunmodulierende verbindungen
AR045689A1 (es) 2003-05-29 2005-11-09 Millennium Pharm Inc Compuestos derivados de 2,5-dihidro-pirazolo[4,3-c]quinolin-4-ona como inhibidores de chk-1 y composiciones farmaceuticas que los contienen
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
AU2006287378A1 (en) 2005-09-07 2007-03-15 Braincells, Inc. Modulation of neurogenesis by HDac inhibition
JP2008047893A (ja) * 2006-08-11 2008-02-28 Samsung Electronics Co Ltd 薄膜トランジスタ表示板及びその製造方法
ES2386168T3 (es) * 2007-06-08 2012-08-10 Helicon Therapeutics, Inc. Derivados de pirazoloquinolina terapéuticos

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108431000A (zh) * 2015-11-16 2018-08-21 基础应用医学研究基金会 作为dna甲基转移酶抑制剂的新型化合物
CN105294648A (zh) * 2015-11-30 2016-02-03 山东罗欣药业集团股份有限公司 一种西他沙星的制备方法
WO2022037631A1 (zh) * 2020-08-21 2022-02-24 浙江海正药业股份有限公司 杂环类衍生物及其制备方法和用途

Also Published As

Publication number Publication date
JP2010529143A (ja) 2010-08-26
ATE544344T1 (de) 2012-02-15
AU2008261884A1 (en) 2008-12-18
EP2166852A1 (en) 2010-03-31
ES2386168T3 (es) 2012-08-10
IL202270A0 (en) 2010-06-16
BRPI0812366A2 (pt) 2016-08-02
EP2166852B1 (en) 2012-02-08
US20110065693A1 (en) 2011-03-17
HK1142775A1 (en) 2010-12-17
US8598159B2 (en) 2013-12-03
US7872002B2 (en) 2011-01-18
MX2009013202A (es) 2010-04-09
US20080306049A1 (en) 2008-12-11
EP2166852A4 (en) 2010-07-07
WO2008154438A1 (en) 2008-12-18
CA2688395A1 (en) 2008-12-18
KR20100039331A (ko) 2010-04-15

Similar Documents

Publication Publication Date Title
CN101742908A (zh) 治疗用吡唑并喹啉衍生物
CN101686682A (zh) 治疗用吡唑并喹啉脲衍生物
US8497262B2 (en) Therapeutic pyrazolonaphthyridine derivatives
JP2010529145A5 (enExample)
HK1144891A (zh) 治疗用吡唑并喹啉衍生物
HK1142776A (en) Therapeutic pyrazoloquinoline urea derivatives
HK1142775B (en) Therapeutic pyrazoloquinoline derivatives
US9012470B2 (en) Therapeutic 5,6,5-tricyclic analogs
HK1144892A (en) Therapeutic pyrazolonaphthyridine derivatives
HK1142496B (en) Therapeutic pyrazoloquinoline urea derivatives
HK1142774B (en) Therapeutic pyrazolonaphthyridine derivatives

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1144891

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20100616

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1144891

Country of ref document: HK